InVivoMAb anti-human CD3

Liu H, Schneider H, Recino A, et al. The Immune Adaptor SLP-76 Binds to SUMO-RANGAP1 at Nuclear Pore Complex Filaments to Regulate Nuclear Import of Transcription Factors in T Cells. Mol Cell. 2015,59(5):840-9. doi: 10.1016/j.molcel.2015.07.015

Rochman Y, Yukawa M, Kartashov AV, et al. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS One. 2015,10(4):e0122198. doi: 10.1371/journal.pone.0122198

Hill EV, Ng TH, Burton BR, et al. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+) effector T-cell subsets through epigenetic modification of the IL-10 promoter. Eur J Immunol. 2015,45(4):1103-15. doi: 10.1002/eji.201444661

Stürner KH, Borgmeyer U, Schulze C, et al. A multiple sclerosis-associated variant of CBLB links genetic risk with type I IFN function. J Immunol. 2014,193(9):4439-47. doi: 10.4049/jimmunol.1303077

Willing A, Leach OA, Ufer F, et al. CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol. 2014,44(10):3119-28. doi: 10.1002/eji.201344160

Esposito L, Hunter KM, Clark J, et al. Investigation of soluble and transmembrane CTLA-4 isoforms in serum and microvesicles. J Immunol. 2014,193(2):889-900. doi: 10.4049/jimmunol.1303389

Wunderlich M, Brooks RA, Panchal R, et al. OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues. Blood. 2014,123(24):e134-44. doi: 10.1182/blood-2014-02-556340

Lines JL, Pantazi E, Mak J, et al. VISTA is an immune checkpoint molecule for human T cells. Cancer Res. 2014,74(7):1924-32. doi: 10.1158/0008-5472.CAN-13-1504